title: Lack of effect of risperidone or olanzapine dose reduction on metabolic parameters, prolactin, and corrected QT interval in stable patients with schizophrenia.
authors.affiliation: Department of Neuropsychiatry Keio University School of Medicine Tokyo, Japan and Schizophrenia Division Complex Mental Illness Program Centre for Addiction and Mental Health Toronto, Ontario, Canada hirotak@dk9.so-net.ne.jp Department of Neuropsychiatry Keio University School of Medicine and Department of Psychiatry Inokashira Hospital Tokyo, Japan Schizophrenia Division Complex Mental Illness Program and Campbell Family Mental Health Research Institute Centre for Addiction and Mental Health Toronto, Ontario, Canada Department of Neuropsychiatry Kyorin University School of Medicine Tokyo, Japan Department of Neuropsychiatry Keio University School of Medicine Tokyo, Japan Department of Neuropsychiatry Keio University School of Medicine Tokyo, Japan and Geriatric Mental Health Program Centre for Addiction and Mental Health Toronto, Ontario, Canada.
authors.forename: Hiroyoshi
authors.initials: H
authors.lastname: Takeuchi
authors.forename: Takefumi
authors.initials: T
authors.lastname: Suzuki
authors.forename: Gary
authors.initials: G
authors.lastname: Remington
authors.forename: Koichiro
authors.initials: K
authors.lastname: Watanabe
authors.forename: Masaru
authors.initials: M
authors.lastname: Mimura
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Uchida
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage; D001569:Benzodiazepines / Q000008:administration & dosage*; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005260:Female; D006339:Heart Rate / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D011388:Prolactin / Q000097:blood*; D018967:Risperidone / Q000008:administration & dosage*; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents; D015415:Biomarkers; D001569:Benzodiazepines; D011388:Prolactin; D018967:Risperidone; D000077152:Olanzapine